The DOI matches its Crossref record; 22 of the 25 references it cites were found in a registry or an index; 6 of the 21 sources its claims cite were checked for support.
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
Open accessAbstract
The aim of this article is to describe epidemiological and clinical data of patients with tuberculous lymphadenitis (TL) and evaluate the yield of the diagnostic techniques employed. Retrospective observational study was performed at the Vall d'Hebron University Hospital, Barcelona, Spain. All adult patients with confirmed TL (microbiologically) or probable TL (suspected by clinical presentation, cyto/histopathological features, and clinical improvement after specific treatment) diagnosed from January 2001 to December 2013 were included. One hundred twenty-two patients were included: 78 (63.9%) patients with confirmed diagnosis and 44 (36.1%) patients with probable TL. Seventy (57.4%) patients were nonnative residents. From 83 fine-needle aspiration (FNA) specimens, 54.8% (40/73) showed granulomatous inflammation, 62.5% (40/64) had positive mycobacterial culture, and 73.3% (11/15) tested positive with Xpert MTB/RIF (Cepheid, Sunnyvale, CA). From 62 biopsy samples, 96.8% (60/62) showed granulomatous inflammation, 64.6% (31/48) had positive mycobacterial culture, and 46.1% (6/13) tested positive with Xpert MTB/RIF. TL has increasingly been diagnosed in our setting, mostly because of cases diagnosed in nonnative residents. FNA is an easy and safe technique for the diagnosis of suspected TL, and the yield regarding mycobacterial culture seems to be similar to the obtained with biopsy. The Xpert MTB/RIF test from FNA specimens may increase the accuracy of the TL diagnosis and provides quicker results.
Overview
CoChat Summary
## TL;DR
This retrospective single-center study of 122 adult tuberculous lymphadenitis (TL) cases in Barcelona found that TL was increasingly diagnosed over time, largely in nonnative residents. Fine-needle aspiration (FNA) and biopsy had similar mycobacterial culture yields, while Xpert MTB/RIF on FNA showed promising but still limited performance.
## Key findings
- 122 patients were included: 78 (63.9%) had confirmed TL and 44 (36.1%) had probable TL.
- 70/122 (57.4%) patients were nonnative residents; among them, the largest groups were from Pakistan (21/70, 17.2%) and Morocco (17/70, 13.9%).
- Diagnostic yields differed by specimen type:
- FNA: granulomatous inflammation 54.8% (40/73), mycobacterial culture 62.5% (40/64), Xpert MTB/RIF 73.3% (11/15).
- Biopsy: granulomatous inflammation 96.8% (60/62), mycobacterial culture 64.6% (31/48), Xpert MTB/RIF 46.1% (6/13).
- Overall, Xpert MTB/RIF was positive in 17/28 (60.7%) tested patients; using culture as reference, sensitivity was 68.8% and specificity 50%, with FNA samples showing 71.4% sensitivity and 25% specificity.
## Methods
- Retrospective observational study at Vall d’Hebron University Hospital (Barcelona, Spain) including adult patients (≥18 years) diagnosed from January 2001 to December 2013 with confirmed TL (mycobacterial culture or PCR) or probable TL (clinical presentation, cyto/histopathology, and improvement after specific treatment).
- Data collected included epidemiology, clinical features, tuberculin skin test, microbiology (AFB stain, culture, PCR/Xpert MTB/RIF, drug resistance), and cyto/histopathology from FNA and biopsy samples.
- Main analysis was descriptive with comparisons of categorical and continuous variables using χ²/Fisher exact tests and Mann–Whitney U/Student t tests.
## Limitations
- The paper states the study is limited by its retrospective nature: reliance on medical records, different physicians, and different tests performed.
- The authors note possible selection bias in choosing FNA vs biopsy, because procedure choice may have been influenced by lesion accessibility/size and suspicion of other diagnoses.
- The study included 44 probable TL cases, which the authors say could have included non-tuberculous diseases that improved during incorrect therapy; this is a limitation stated in the paper.
- Evident from the text: Xpert MTB/RIF was performed in only 28 patients, so estimates for this test are based on a small sample.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
3 Valid · 0 Not valid · 6 Not checked · 43 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cervical territory was affected in 73 (59.8%) patients”
§ Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country > RESULTS
plainn = 122- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of these 122 patients, 54 (43.3%) patients were men, median age was 38 (18–83) years and median time from the beginning of symptoms to consultation was 2 (1–48) months.”
§ Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country > RESULTS
plainn = 122- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of these 122 patients, 54 (43.3%) patients were men, median age was 38 (18–83) years and median time from the beginning of symptoms to consultation was 2 (1–48) months.”
§ Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country > RESULTS
plainn = 122- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Seventy (57.4%) patients were nonnative residents.”
- Also stated in: § RESULTS · plain
“of the 70 (57.4%) nonnative patients, 21 (17.2%) were from Pakistan, 17 (13.9%) were from Morocco, 9 (7.4%) were from Ecuador, 6 (4.9%) were from Bolivia, and 17 (13.9%) were from other countries.”
§ Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country > Abstract
plainn = 122- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § RESULTS · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Regarding nodal territories involved, 75 (61.5%) patients had 1 territory affected and 47 (38.5%) patients had >1 territory affected.”
§ Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country > RESULTS
plainn = 122- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 52 claims and every source verdict.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 10
Citations
Cites
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527 · cited 1×
“Scarce information about the role of these techniques in the diagnosis of TL has been published, and results are very different depending on the study.(6,7) In this study, we present epidemiological and clinical data of patients with TL diagnosed at Vall d’Hebron University Hospital (HUVH) during the last decade, and…”
MethodRapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413
Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?
Vadwai, V., Boehme, C., Nabeta, P., Shetty, A., Alland, D., & Rodrigues, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02319-10 · Cited by 357
Tuberculosis in HIV-infected patients: a comprehensive review
Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., Marchal, G., Dupont, B., Bouchaud, O., Valeyre, D., et al. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00758.x · Cited by 330 · cited 1×
“infection; in these patients, the disease is almost always secondary to reactivation of a latent tuberculosis infection.(12) The present study shows a prevalence of HIV infection among patients with TL of 15.”
BackgroundClinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299 · cited 1×
“Culture remains the gold standard for diagnosis, but results may take 3 to 4 weeks.(4) A positive acidfast bacilli (AFB) stain may indicate mycobacterial disease, although sensitivity is lower than culture, ranging from 5% to 38% depending on the studies.”
BackgroundEfficacy of fine needle aspiration cytology in the diagnosis of tuberculous cervical lymphadenopathy
Lau, S. K., Wei, W. I., Hsu, C., & Engzell, U. C. G. (1990) · The Journal of Laryngology & Otology · doi:10.1017/s0022215100111697 · Cited by 176
Peripheral Tuberculous Lymphadenitis: Epidemiology, Diagnosis, Treatment, and Outcome
Polesky, A., Grove, W., & Bhatia, G. (2005) · Medicine · doi:10.1097/01.md.0000189090.52626.7a · Cited by 165 · cited 2×
“A positive acidfast bacilli (AFB) stain may indicate mycobacterial disease, although sensitivity is lower than culture, ranging from 5% to 38% depending on the studies.(3,5) In AFB-negative and/or culture-negative cases, histological features, such as granulomas with or without caseous necrosis, or nonspecific lymphad…”
BackgroundGreco, S., Girardi, E., Navarra, A., & Saltini, C. (2006) · Thorax · doi:10.1136/thx.2005.054908 · Cited by 162 · cited 1×
“Nucleic acid detection by PCR has been widely used to diagnose pulmonary tuberculosis.(17) Regarding the accuracy of these techniques in the diagnosis of TL, a systematic review was published in 2007 by Daley et al,(6) showing very heterogeneous results, with a sensitivity ranging from 2% to 100% depending on the stud…”
MethodComparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary Tuberculosis
Causse, M., Ruiz, P., Gutiérrez-Aroca, J. B., & Casal, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00491-11 · Cited by 145
Cited by
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Ankrah, A. O., Glaudemans, A. W. J. M., Maes, A., de Wiele, C. V., Dierckx, R., Vorster, M., & Sathekge, M. M. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.10.005 · Cited by 117
Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosis
Park, M., & Kon, O. M. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1810565 · Cited by 69
Ladumor, H., Al‐Mohannadi, S., Ameerudeen, F. S., Ladumor, S. B., & Fadl, S. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.02.012 · Cited by 68
Metadata
- Authors
- Salvador, F., Los-Arcos, I., Sánchez-Montalvá, A., Tórtola, T., Curran, A., Villar, A., Saborit, N., Castellví, J., & Molina, I.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- Corresponding author
- Salvador, Fernando
- Venue
- Medicine
- Published
- 2015-01
- Volume
- 94
- Issue
- 4
- Pages
- e509
- ISSN
- 0025-7974 (ISSN-L)
- 1536-5964
- PMC
- PMC4602977
- OpenAlex
- W2329773059
- Cited by
- 43
- References
- 25
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 9 · 2019: 3 · 2018: 2 · 2017: 6 · 2016: 2
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Medicine (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphadenopathy Diagnosis and Analysis
- Keywords
- tuberculous lymphadenitis, tuberculosis epidemiology, diagnostic yield, fine-needle aspiration, Xpert MTB/RIF, mycobacterial culture, lymph node biopsy, granulomatous inflammation
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Granuloma, Humans, Lymph Nodes, Male, Middle Aged, Mycobacterium tuberculosis, Retrospective Studies, Sensitivity and Specificity, Spain, Tuberculosis, Lymph Node, HIV Infections, Polymerase Chain Reaction, Biopsy, Fine-Needle, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country. https://app.cochat.ai/papers/10.1097/md.0000000000000509
- The paper
- Salvador, F., Los-Arcos, I., Sánchez-Montalvá, A., Tórtola, T., Curran, A., Villar, A., Saborit, N., Castellví, J., & Molina, I. (2015). Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country. Medicine. https://doi.org/10.1097/md.0000000000000509
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.